Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews · Gynaecology and Fertility

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 28.6%Moderate 5 · 71.4%High 0 · 0%

Moderate dose SSRI versus placebo Luteal or continuous administration · women with premenstrual syndrome

1 finding from 1 review

Selective serotonin reuptake inhibitors for premenstrual syndrome 2013 · Cochrane Headline outcomes only
no estimate extracted
9 studies · 1276 participants
Low

Moderate dose SSRI versus placebo Luteal administration · women with premenstrual syndrome

1 finding from 1 review

Selective serotonin reuptake inhibitors for premenstrual syndrome 2013 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 457 participants
Moderate

Moderate dose SSRI versus placebo Continuous administration · women with premenstrual syndrome

1 finding from 1 review

Selective serotonin reuptake inhibitors for premenstrual syndrome 2013 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 843 participants
Low

Moderate dose SSRI versus placebo Luteal administration2 · women with premenstrual syndrome

1 finding from 1 review

Selective serotonin reuptake inhibitors for premenstrual syndrome 2013 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 657 participants
Moderate

Low dose SSRI versus placebo Luteal or continuous administration · women with premenstrual syndrome

The intervention probably leads to higher low dose SSRI versus placebo Luteal or continuous administration (moderate certainty).

1 finding from 1 review

Selective serotonin reuptake inhibitors for premenstrual syndrome 2013 · Cochrane Headline outcomes only
OR 1.76 [1.13, 2.75]
7 studies · 1301 participants
Moderate

Mod dose SSRI versus placebo Luteal or continuous administration · women with premenstrual syndrome

The intervention probably leads to higher mod dose SSRI versus placebo Luteal or continuous administration (moderate certainty).

1 finding from 1 review

Selective serotonin reuptake inhibitors for premenstrual syndrome 2013 · Cochrane Headline outcomes only
OR 2.55 [1.84, 3.53]
15 studies · 2447 participants
Moderate

High dose SSRIs versus placebo Continuous administration · women with premenstrual syndrome

The intervention probably leads to higher high dose SSRIs versus placebo Continuous administration (moderate certainty).

1 finding from 1 review

Selective serotonin reuptake inhibitors for premenstrual syndrome 2013 · Cochrane Headline outcomes only
RR 6.35 [2.88, 14]
1 study · 231 participants
Moderate